医药营销
- (2022-02-25)
- (2022-02-25)
- (2022-02-25)
- (2022-02-25)
- (2022-02-25)
- (2022-02-25)
- (2022-02-25)
开创中国特应性皮炎(AD)口服靶向治疗新时代:阿尔贝提口服JAK抑制剂Rinvoq (Upatinib)获得美国食品药品监督管理局批准!
(2022-02-25)- (2022-02-24)
- (2022-02-24)
- (2022-02-24)
- (2022-02-24)
- (2022-02-24)
- (2022-02-24)
- (2022-02-24)
- (2022-02-24)
- (2022-02-24)
- (2022-02-24)
- (2022-02-24)
- (2022-02-23)
- (2022-02-23)
- (2022-02-23)
- (2022-02-23)
- (2022-02-23)
- (2022-02-23)
- (2022-02-22)
- (2022-02-22)
- (2022-02-22)
- (2022-02-22)
- (2022-02-22)
- (2022-02-22)
- (2022-02-22)
- (2022-02-22)
- (2022-02-22)
- (2022-02-22)
- (2022-02-21)
- (2022-02-21)
- (2022-02-21)
- (2022-02-21)
- (2022-02-21)
- (2022-02-21)
- (2022-02-21)
- (2022-02-21)
- (2022-02-21)
- (2022-02-21)
- (2022-02-21)
- (2022-02-20)
- (2022-02-20)
- (2022-02-20)
- (2022-02-20)
- (2022-02-20)
- (2022-02-19)
- (2022-02-19)
- (2022-02-19)
- (2022-02-19)
- (2022-02-19)
- (2022-02-19)
- (2022-02-18)
- (2022-02-18)
- (2022-02-18)